| Company Name |
Form Type |
SEC Filings |
|
|
|
|
RVL Pharmaceuticals plc
|
25-NSE
|
Financial Statements
|
|
Ontrak, Inc.
|
25-NSE
|
|
|
SHIFT TECHNOLOGIES, INC.
|
25-NSE
|
|
|
EBET, Inc.
|
25-NSE
|
Financial Statements
|
|
Molekule Group, Inc.
|
25-NSE
|
|
|
INFINITY PHARMACEUTICALS, INC.
|
25-NSE
|
Financial Statements
|
|
Kiromic Biopharma, Inc.
|
25-NSE
|
Financial Statements
|
|
Mereo Biopharma Group plc
|
SC 13D/A
|
Financial Statements
|
|
Rubric Capital Management LP
|
SC 13D/A
|
|
|
Post Holdings, Inc.
|
PRE 14A
|
Financial Statements
|
|
Lingrove Inc.
|
D
|
|
|
Financial Strategies Acquisition Corp.
|
25-NSE
|
|
|
Genesis Growth Tech Acquisition Corp.
|
25-NSE
|
|
|
Pono Capital Three, Inc.
|
S-4/A
|
|
|
KOHLS Corp
|
8-K
|
Financial Statements
|
|
U Power Ltd
|
F-1
|
|
|
CENTRUS ENERGY CORP
|
8-K
|
Financial Statements
|
|
Safety Shot, Inc.
|
8-K
|
|
|
Popolo Joseph V
|
4
|
|
|
Ondas Holdings Inc.
|
4
|
|
|
Alpha Tau Medical Ltd.
|
6-K
|
|
|
Rubinstein Samuel
|
4
|
|
|
STRATA Skin Sciences, Inc.
|
4
|
Financial Statements
|
|
DIVERSIFIED HEALTHCARE TRUST
|
8-K
|
|
|
Staffing 360 Solutions, Inc.
|
8-K
|
Financial Statements
|
|
Foresight Autonomous Holdings Ltd.
|
6-K
|
Financial Statements
|
|
Abcam plc
|
SC 13D/A
|
Financial Statements
|
|
HBK INVESTMENTS L P
|
SC 13D/A
|
|
|
Volcon, Inc.
|
8-K
|
Financial Statements
|
|
ABVC BIOPHARMA, INC.
|
8-K
|
|
|
OFFICE PROPERTIES INCOME TRUST
|
8-K
|
|
|
Abacus Life, Inc.
|
8-K
|
|
|
OCUFII, INC.
|
D
|
|
|
Myers Linda Kristine
|
4
|
|
|
NORFOLK SOUTHERN CORP
|
424B5
|
Financial Statements
|
|
Enfusion, Inc.
|
8-K
|
Financial Statements
|
|
NRG ENERGY, INC.
|
8-K
|
Financial Statements
|
|
Nargolwala Vineet A
|
4
|
|
|
ALLEGRO MICROSYSTEMS, INC.
|
4
|
Financial Statements
|
|
Sol-Gel Technologies Ltd.
|
6-K
|
Financial Statements
|
|
Daly Joseph Patrick
|
4
|
|
|
BUTLER NATIONAL CORP
|
4
|
|
|
ROYAL BANK OF CANADA
|
424B2
|
Financial Statements
|
|
FASTENAL CO
|
8-K
|
Financial Statements
|
|
Bitfarms Ltd
|
F-10/A
|
|
|
MIRA PHARMACEUTICALS, INC.
|
8-K
|
|
|
Marvion Inc.
|
10-Q
|
|
|
GTE Holdings LLC
|
D
|
|
|
Tracon Pharmaceuticals, Inc.
|
8-K
|
Financial Statements
|
|
SaverOne 2014 Ltd.
|
6-K
|
|
|
Ark 21Shares Bitcoin ETF
|
S-1/A
|
|
|
PACIFIC PREMIER BANCORP INC
|
8-K
|
Financial Statements
|
|
McCarthy Daniel Joseph
|
4
|
|
|
Evolent Health, Inc.
|
4
|
Financial Statements
|
|
Denhoy Raj
|
4
|
|
|
ESTABLISHMENT LABS HOLDINGS INC.
|
4
|
Financial Statements
|
|
PATRICK BAILEY W
|
4
|
|
|
CATO CORP
|
4
|
Financial Statements
|
|
Tarica Laurence
|
4
|
|
|
Gannett Co., Inc.
|
4
|
Financial Statements
|
|
Samsara Luggage, Inc.
|
10-Q
|
|
|
EXAGEN INC.
|
424B5
|
Financial Statements
|
|
Cuentas Inc.
|
10-Q
|
|
|
VBI Vaccines Inc/BC
|
8-K
|
Financial Statements
|
|
Spectaire Holdings Inc.
|
8-K
|
|
|
ALTERITY THERAPEUTICS LTD
|
6-K
|
Financial Statements
|
|
Greenvale Capital LLP
|
SC 13G/A
|
|
|
2U, Inc.
|
SC 13G/A
|
Financial Statements
|
|
Rani Therapeutics Holdings, Inc.
|
4
|
Financial Statements
|
|
Nanavaty Maulik
|
4
|
|
|
Hammerhead Energy Inc.
|
6-K
|
|
|
Burke & Herbert Financial Services Corp.
|
425
|
|
|
SUMMIT FINANCIAL GROUP, INC.
|
425
|
Financial Statements
|
|
Burke & Herbert Financial Services Corp.
|
8-K
|
|
|
FTC Solar, Inc.
|
4
|
Financial Statements
|
|
PRIDDY WILLIAM A
|
4
|
|
|
SEQUANS COMMUNICATIONS
|
SC 13E3/A
|
Financial Statements
|
|
Blue Bird Corp
|
8-K
|
Financial Statements
|
|
SEQUANS COMMUNICATIONS
|
SC 14D9/A
|
Financial Statements
|
|
VEON Ltd.
|
6-K
|
Financial Statements
|
|
OurCrowd
|
D
|
|
|
ADIAL PHARMACEUTICALS, INC.
|
424B3
|
Financial Statements
|
|
Bone Biologics Corp
|
8-K
|
|
|
NEW RELIC, INC.
|
15-12G
|
Financial Statements
|
|
Conway Kiernan
|
4
|
|
|
UMH PROPERTIES, INC.
|
4
|
Financial Statements
|
|
Cazoo Group Ltd
|
424B3
|
|
|
Consolidated Communications Holdings, Inc.
|
PREM14A
|
Financial Statements
|
|
Bone Biologics Corp
|
424B5
|
|
|
Renesas Electronics Corp
|
SC TO-T/A
|
|
|
SEQUANS COMMUNICATIONS
|
SC TO-T/A
|
Financial Statements
|
|
Fenbo Holdings Ltd
|
F-1/A
|
|
|
VODAFONE GROUP PUBLIC LTD CO
|
6-K
|
Financial Statements
|
|
Nechmad Amir Alimelech
|
144
|
|
|
Nayax Ltd.
|
144
|
|
|
ZEVRA THERAPEUTICS, INC.
|
8-K
|
Financial Statements
|
|
Taysha Gene Therapies, Inc.
|
4
|
Financial Statements
|
|
Manning Paul B
|
4
|
|
|
Israel Resilience Fund, L.P.
|
D
|
|
|
Matinas BioPharma Holdings, Inc.
|
8-K
|
Financial Statements
|
|
AIM ImmunoTech Inc.
|
DEFA14A
|
|
|
Brainsway Ltd.
|
6-K
|
Financial Statements
|
|
Tingo Group, Inc.
|
10-Q
|
Financial Statements
|
|
SASOL LTD
|
6-K
|
Financial Statements
|
|
Patterson Robert M
|
4
|
|
|
AVIENT CORP
|
4
|
|
|
So-Young International Inc.
|
6-K
|
Financial Statements
|
|
2seventy bio, Inc.
|
8-K
|
|
|
RYANAIR HOLDINGS PLC
|
6-K
|
Financial Statements
|
|
Badger Kyle C
|
4
|
|
|
AGILYSYS INC
|
4
|
Financial Statements
|
|
Robertson Chris J
|
4
|
|
|
Wood William David III
|
4
|
|
|
WEC ENERGY GROUP, INC.
|
8-K
|
Financial Statements
|
|
Leet Technology Inc.
|
10-Q
|
|
|
Karsanbhai Surendralal Lanca
|
4
|
|
|
Crypto Co
|
10-Q
|
|
|
C4 Therapeutics, Inc.
|
8-K
|
Financial Statements
|
|
ProMIS Neurosciences Inc.
|
8-K
|
|
|
BioLineRx Ltd.
|
6-K
|
Financial Statements
|
|
PLUS THERAPEUTICS, INC.
|
8-K
|
|
|
Hostess Brands, Inc.
|
15-12G
|
Financial Statements
|
|
DR REDDYS LABORATORIES LTD
|
6-K
|
Financial Statements
|
|
T. Rowe Price Retirement Funds, Inc.
|
EFFECT
|
|
|
GUGGENHEIM DEFINED PORTFOLIOS, SERIES 2366
|
EFFECT
|
|
|
Sonoma Pharmaceuticals, Inc.
|
EFFECT
|
Financial Statements
|
|
INTEST CORP
|
EFFECT
|
Financial Statements
|
|
Verastem, Inc.
|
EFFECT
|
Financial Statements
|
|
PaxMedica, Inc.
|
EFFECT
|
Financial Statements
|
|
COLOMBIER ACQUISITION CORP. II
|
EFFECT
|
|
|
Aeglea BioTherapeutics, Inc.
|
EFFECT
|
Financial Statements
|
|
Arcadium Lithium plc
|
EFFECT
|
|
|
PLUS THERAPEUTICS, INC.
|
EFFECT
|
|
|
Vado Corp.
|
QUALIF
|
|
|
TELA Bio, Inc.
|
EFFECT
|
Financial Statements
|
|
P3 Health Partners Inc.
|
EFFECT
|
|
|
ClearPoint Neuro, Inc.
|
EFFECT
|
Financial Statements
|
|
Arrived Homes 3, LLC
|
QUALIF
|
|
|
DIEBOLD NIXDORF, Inc
|
EFFECT
|
Financial Statements
|
|
Westrock Coffee Co
|
EFFECT
|
|
|
Ark7 Properties Plus LLC
|
QUALIF
|
|
|
aTYR PHARMA INC
|
EFFECT
|
Financial Statements
|
|
Happel David
|
4
|
|
|
Sagimet Biosciences Inc.
|
4
|
|
|
Kayne Anderson Energy Infrastructure Fund, Inc.
|
4
|
Financial Statements
|
|
Hart Terry A
|
4
|
|
|
Encrantz Staffan
|
4
|
|
|
Sight Sciences, Inc.
|
4
|
Financial Statements
|
|
Insight Venture Associates IX, Ltd.
|
4
|
|
|
Insight Venture Associates IX, L.P.
|
4
|
|
|
Insight Venture Partners IX
|
4
|
|
|
Insight Venture Partners
|
4
|
|
|
Insight Venture Partners IX, L.P.
|
4
|
|
|
Insight Venture Partners
|
4
|
|
|
1stdibs.com, Inc.
|
4
|
Financial Statements
|
|
Insight Holdings Group, LLC
|
4
|
|
|
Shea William H JR
|
4
|
|
|
KAYNE ANDERSON CAPITAL ADVISORS LP
|
4
|
|
|
Bolt Biotherapeutics, Inc.
|
4
|
Financial Statements
|
|
ENGLEMAN EDGAR
|
4
|
|
|
Accel-KKR Holdings GP, LLC
|
4
|
|
|
Accel-KKR Members Fund, LLC
|
4
|
|
|
Paymentus Holdings, Inc.
|
4
|
Financial Statements
|
|
ACCEL-KKR CAPITAL PARTNERS CV III, LP
|
4
|
|
|
ACCEL-KKR GROWTH CAPITAL PARTNERS III, LP
|
4
|
|
|
Accel-KKR Growth Capital Partners II Strategic Fund, LP
|
4
|
|
|
Accel-KKR Growth Capital Partners II, LP
|
4
|
|
|
Nasser Andrew
|
3
|
|
|
COLOMBIER ACQUISITION CORP. II
|
3
|
|
|
Cohen Jordan
|
3
|
|
|
Buskirk Christopher
|
3
|
|
|
Voboril Joseph
|
3
|
|
|
Seifert Michael Stephen
|
3
|
|
|
Barnds Thomas
|
4
|
|
|
Colombier Sponsor II LLC
|
3
|
|
|
Malik Omeed
|
3
|
|
|
Kavanaugh Ryan
|
3
|
|
|
Willoughby Candice
|
3
|
|
|
Palumbo Robert
|
4
|
|
|
Mauro Garry Paul
|
4
|
|
|
Lifevantage Corp
|
4
|
Financial Statements
|
|
Lewis Darwin
|
4
|
|
|
Latham Cynthia
|
4
|
|
|
Greer Raymond B
|
4
|
|
|
Fife Steven R
|
4
|
|
|
Brockovich Erin
|
4
|
|
|
BEINDORFF MICHAEL A
|
4
|
|
|
Shift4 Payments, Inc.
|
4
|
Financial Statements
|
|
Disman Nancy
|
4
|
|
|
Richey Albert L
|
4
|
|
|
FENNEC PHARMACEUTICALS INC.
|
4
|
Financial Statements
|
|
RALLIS CHRIS A
|
4
|
|
|
Brookfield Asset Management ULC
|
3
|
|
|
BAM Partners Trust
|
3
|
|
|
IMPEL PHARMACEUTICALS INC
|
3
|
Financial Statements
|
|
BROOKFIELD Corp /ON/
|
3
|
|
|
McGarry Kimberly J
|
4
|
|
|
Morningstar, Inc.
|
4
|
Financial Statements
|
|
Farrell Michael J.
|
4/A
|
|
|
RESMED INC
|
4/A
|
Financial Statements
|
|
Ramaco Resources, Inc.
|
4
|
Financial Statements
|
|
LEIDEL PETER A
|
4
|
|
|
LAWRENCE BRYAN H
|
4
|
|
|
Yorktown XI Associates LLC
|
4
|
|
|
Yorktown Energy Partners XI, L.P.
|
4
|
|
|
Yorktown IX Associates LLC
|
4
|
|
|
Yorktown Energy Partners IX, L.P.
|
4
|
|
|
Oaktree LSL Fund Holdings EURRC S.a.r.l.
|
3
|
|
|
Oaktree GCP Fund Delaware Holdings, L.P.
|
3
|
|
|
Oaktree PRE Life Sciences Fund, L.P.
|
3
|
|
|
Oaktree LSL Fund Delaware Holdings EURRC, L.P.
|
3
|
|
|
Oaktree Loan Acquisition Fund, L.P.
|
3
|
|
|
Oaktree AZ Strategic Lending Fund, L.P.
|
3
|
|
|
Oaktree Diversified Income Fund Inc.
|
3
|
|
|
Atlas OCM Holdings, LLC
|
3
|
|
|
Oaktree Capital Group, LLC
|
3
|
|
|
INPRS Strategic Credit Holdings, LLC
|
3
|
|
|
Oaktree Strategic Credit Fund
|
3
|
|
|
Oaktree Gilead Investment Fund AIF
|
3
|
|
|
Oaktree-TSE 16 Strategic Credit, LLC
|
3
|
|
|
Oaktree-TBMR Strategic Credit Fund C, LLC
|
3
|
|
|
Oaktree-TBMR Strategic Credit Fund F, LLC
|
3
|
|
|
Oaktree-TBMR Strategic Credit Fund G, LLC
|
3
|
|
|
Oaktree-TCDRS Strategic Credit, LLC
|
3
|
|
|
Oaktree-Forrest Multi-Strategy,LLC
|
3
|
|
|
Oaktree Specialty Lending Corp
|
3
|
Financial Statements
|
|
Vivo Opportunity Fund Holdings, L.P.
|
4
|
|
|
Vivo Panda, LLC
|
4
|
|
|
Vivo Opportunity, LLC
|
4
|
|
|
Vivo Panda Fund, L.P.
|
4
|
|
|
Vivo Capital Surplus Fund VIII, L.P.
|
4
|
|
|
Vivo Capital VIII, LLC
|
4
|
|
|
Vivo Capital Fund VIII, L.P.
|
4
|
|
|
McIntyre Shauna
|
4
|
|
|
LITHIA MOTORS INC
|
4
|
Financial Statements
|
|
Uber Technologies, Inc
|
4
|
Financial Statements
|
|
Ceremony Glen
|
4
|
|
|
Krishnamurthy Nikki
|
4
|
|
|
West Tony
|
4
|
|
|
PEARL BARRY R
|
4
|
|
|
Hazelbaker Jill
|
4
|
|
|
Shanmugam Muthusamy
|
4
|
|
|
ANI PHARMACEUTICALS INC
|
4
|
Financial Statements
|
|
Zalevsky Jonathan
|
4
|
|
|
NEKTAR THERAPEUTICS
|
4
|
Financial Statements
|
|
Costin Anne K
|
4
|
|
|
Wilson Mark Andrew
|
4
|
|
|
ROBIN HOWARD W
|
4
|
|
|
Shanmugam Muthusamy
|
4/A
|
|
|
ANI PHARMACEUTICALS INC
|
4/A
|
Financial Statements
|
|
TransDigm Group INC
|
4
|
Financial Statements
|
|
SMALL ROBERT J
|
4
|
|
|
Pulse Biosciences, Inc.
|
4
|
Financial Statements
|
|
DUGGAN ROBERT W
|
4
|
|
|
Cordes William R
|
4
|
|
|
Newton Charles W.
|
4
|
|
|
Lyell Immunopharma, Inc.
|
4
|
Financial Statements
|
|
Lee Gary K.
|
4
|
|
|
Seely Lynn
|
4
|
|
|
Kapoor Kunal
|
4
|
|
|
Hill Stephen J.
|
4
|
|
|
Campbell Michael Earl
|
4
|
|
|
EQUINIX INC
|
4
|
Financial Statements
|
|
COLOMBIER ACQUISITION CORP. II
|
S-1MEF
|
|
|
Fox Mary
|
4
|
|
|
Lovesac Co
|
4
|
Financial Statements
|
|
Zaccaro Joanne Caruso
|
4
|
|
|
JACOBS SOLUTIONS INC.
|
4
|
|
|
Gibson Daniel Patrick
|
4
|
|
|
Sylebra Capital Ltd
|
4
|
|
|
IMPINJ INC
|
4
|
Financial Statements
|
|
PRAGADA ROBERT V
|
4
|
|
|
Williams Gregg
|
4
|
|
|
Vivani Medical, Inc.
|
4
|
Financial Statements
|
|
Miller Shannon
|
4
|
|
|
Jaramillo Claudia
|
4
|
|
|
DEMETRIOU STEVEN J.
|
4
|
|
|
SULPIZIO RICHARD
|
4
|
|
|
RESMED INC
|
4
|
Financial Statements
|
|
Arnette Stephen A
|
4
|
|
|
De Witte Jan
|
4
|
|
|
Murdock Michael N
|
4
|
|
|
RadNet, Inc.
|
4
|
Financial Statements
|
|
ALLEN WILLIAM B JR
|
4
|
|
|
Hernandez John
|
4
|
|
|
Gill Harjit
|
4
|
|
|
Cohen Joshua B
|
4
|
|
|
Amylyx Pharmaceuticals, Inc.
|
4
|
Financial Statements
|
|
Jasper Therapeutics, Inc.
|
4
|
|
|
WIGGANS THOMAS G
|
4
|
|
|
Mahendra-Rajah Prashanth
|
3
|
|
|
Uber Technologies, Inc
|
3
|
Financial Statements
|
|
Verma Anubhav
|
4
|
|
|
MICROVISION, INC.
|
4
|
Financial Statements
|
|
Flaherty Scott B.
|
4/A
|
|
|
WILLIS LEASE FINANCE CORP
|
4/A
|
Financial Statements
|
|
Rodino-Klapac Louise
|
4
|
|
|
Sarepta Therapeutics, Inc.
|
4
|
Financial Statements
|
|
NV5 Global, Inc.
|
4
|
Financial Statements
|
|
ALFORD DONALD C
|
4
|
|
